Patents by Inventor Marco Daniel Pascal Lierfeld

Marco Daniel Pascal Lierfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and device for side-effect prognosis and monitoring
    Patent number: 8929625
    Abstract: A method for radiotherapy monitoring is provided. The method comprises calculation of treatment-guiding indices of side-effects based on processing image derived descriptors and measurement values of selected disease specific biomarkers and optionally questionnaire data. A computer program product is also provided.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: January 6, 2015
    Assignee: Koninklijke Philips N.V.
    Inventors: Carolina Ribbing, Martin Weibrecht, Peter Klaus Bachmann, Michael Perkuhn, Marco Daniel Pascal Lierfeld, Michael Pinkawa
  • METHOD OF EVALUATING TOXICITY LEVEL OF A PATIENT UNDERGOING A CANCER TREATMENT
    Publication number: 20120203469
    Abstract: This invention relates to a method and a system of evaluating toxicity level of a patient undergoing a cancer treatment protocol. Patient's related data including biomarkers of toxicity level caused by said cancer treatment are received. These biomarkers of toxicity level are then compared with a range of reference biomarkers of toxicity level caused during a similar cancer treatment. Finally, an alert signal is issued in case the biomarkers of toxicity level fall outside said range of reference biomarkers of toxicity level.
    Type: Application
    Filed: September 27, 2010
    Publication date: August 9, 2012
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Martin Weibrecht, Carolina Ribbing, Marco Daniel Pascal Lierfeld, Frank Wartena
  • METHOD AND DEVICE FOR SIDE-EFFECT PROGNOSIS AND MONITORING
    Publication number: 20120063657
    Abstract: A method for radiotherapy monitoring is provided. The method comprises calculation of treatment-guiding indices of side-effects based on processing image derived descriptors and measurement values of selected disease specific biomarkers and optionally questionnaire data. A computer program product is also provided.
    Type: Application
    Filed: May 21, 2010
    Publication date: March 15, 2012
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Carolina Ribbing, Martin Weibrecht, Peter Klaus Bachmann, Michael Perkuhn, Marco Daniel Pascal Lierfeld, Michael Pinkawa